baber/WOPTO huggingface dataset:
Patent NZ-546727-A (NZ)
Title: A mailable card
Inventor: HEMPEL ANDREW KASIMIR HENRY
IPC: B42D15/04
Filed: 2004-09-24
Abstract: A mailable card (1) includes a first panel (5) of generally rectangular configuration so as to have a pair of side edges and a pair of end edges (25) extending between the side edges. The first panel (5) also having a major front face to receive an image or text and a major rear face (35). A second panel (40) including a first portion (45) securable to the first panel (5) so as to provide in combination with the first panel (5) a pocket to receive a relatively flat object (52). A second portion (55) associated with the first portion (45) and securable to the rear face (35) to close the pocket. Securing means manipulated by a user to secure the second portion (55) to the rear face (35) to close the pocket and an opening means (65) manipulated by a user to permit removal of the object (52) from the pocket.
Patent NZ-546837-A (NZ)
Title: Twist-open closure having inclined frangible membrane
Inventor: MA MIKE XIAOLI
IPC: B67D99/00
Filed: 2004-09-16
Abstract: A closure (30) for a container having an opening is disclosed. The container comprises a base cap (31) which includes an outer skirt (36) having container-engaging structure, a cylindrical well defining a chamber for containing and supporting a consumable or other item located therein, a frangible membrane (41) connected to the well along an inclined line (42) of weakness and by a hinge member. The hinge member has a pocket which extends downwardly adjacent lower and upper terminuses of the line of weakness. Also included is an overcap (32) which includes a body having gripping structure, an inner skirt received within and rotatably positioned relative to the well, and a cutting member (50) depending from a lower end of the inner skirt and substantially received within the pocket. The cutting member (50) extends below the lower terminus when the base cap (31) is assembled to the overcap (32), whereby the cutting member (50) severs the line of weakness upon substantial rotation of the overcap (32) with respect to the base cap (31).
Patent NZ-550934-A (NZ)
Title: Chemical linkers and conjugates thereof
Inventor: HORGAN KILIAN
IPC: A61K49/18
Filed: 2005-05-19
Abstract: Disclosed is a compound of formula (1), wherein the substituents are as listed in the specification and the cleavable linker contains a peptide or an amino acid, which provides drug-ligand conjugates that are potent cytotoxins. Also disclosed are cytotoxins represented by duocarmycins and derivatives thereof.
Patent NZ-552467-A (NZ)
Title: Office chair
Inventor: CHADWICK DONALD T
IPC: A47C1/024
Filed: 2005-07-08
Abstract: A chair such as an office chair has a base, a seat supported by the base, a tilt mechanism between the base and the seat, and a backrest connected to at least one of the seat or the tilt mechanism. The tilt mechanism includes a tilt spring and is connected to the seat so that the seat can move relative to the tilt mechanism and so that movement of the seat activates the tilt spring so that at least one of the seat and the backrest are tilted. A tilt limiter 105 includes a magnetic member 100 which facilitates full movement of the tilt limiter between free and locked positions in which tilting is respectively enabled or prevented, and which creates an audible indication of full movement of the tilt limiter.
Patent NZ-553191-A (NZ)
Title: Low temperature Li/FeS2 battery
Inventor: WEBBER ANDREW A
IPC: H01M4/58
Filed: 2005-08-22
Abstract: Disclosed is an electrochemical battery cell having a negative electrode comprising an alkali metal, a positive electrode, a separator disposed between the negative and positive electrodes, and an electrolyte, wherein the electrolyte comprises a solute comprising greater than 50 weight percent lithium iodide; and a solvent comprising 45 to 80 volume percent 1,2-dimethoxyethane and 5 to 25 volume percent 3-methyl-2-oxazolidinone. Also disclosed is an electrolyte for use in a primary lithium battery cell comprising 0.5 to 2 moles of solute per litre of a solvent; the solute comprises greater than 50 weight percent lithium iodide; and the solvent comprises 45 to 80 volume percent 1,2-dimethoxyethane and 5 to 25 volume percent 3-methyl-2-oxazolidinone.
Patent NZ-556524-A (NZ)
Title: Temperature prediction system and method
Inventor: BUTTERFIELD ROBERT D
IPC: G01K7/42
Filed: 2006-03-24
Abstract: A thermometer for determining the temperature of a subject comprises a sensor that provides temperature signals in response to sensing the temperature of the subject, the temperature signals varying in time; a display; and a processor. The processor is configured to: monitor the temperature signals; adapt a variable shape, nonlinear, multi-parameter model temperature curve to the monitored temperature signals by applying the equation Tfit(n * t) = A *(B/D) and compare the model temperature curve to the monitored temperature signal. Tfit(n * t) is the estimate of the temperature at a particular time t = n *t (0F or 0C); n is an integer sample index initialized to 0 at the first sample meeting conditions for "Prediction Start"; t is a number of seconds per sample (sec); A is an "offset" parameter (0F or 0C); D = 1 + n *t * CE and B is a "span" or "range" parameter (0F or 0C); C is a "curvature" or "rate of equilibration" parameter (sec-1); and E is a "time warp" factor (unit-less) that may be used to make a nonlinear modification of the curvature of the model curve to make it better fit the curve of the temperature data. At least three of the A, B, C, E values are varied in adapting the model temperature curve and the units of Tfit, A, B are all 0F or all 0C The processor is further configured to compare the model temperature curve to the monitored temperature signals; if the differences between the model temperature curve and the monitored temperature signals do not exceed a threshold, predict the temperature of the subject based on the model curve; and provide the predicted temperature to the display. The display displays the predicted temperature.
Patent NZ-561158-A (NZ)
Title: Chemically defined stabiliser composition comprising at least one amino acid, at least one sugar and at least one polyamine
Inventor: GELDER VAN PETRUS
IPC: A61K39/112
Filed: 2006-03-07
Abstract: Disclosed is a vaccine stabiliser composition when used in freeze drying a biological molecule or a micro-organism, said stabiliser composition comprising at least one amino acid, at least one sugar, and at least one polyamine wherein all compounds are chemically defined, thus being free of serum, free of protein, free of animal compounds, free of polymer of which only an average molecular weight or average length of the side chains is known and free of proteinaceous lysate, extract hydrolysate or peptide mixture, wherein the polyamine is at least one selected from the group consisting of ethylene-diamine, cadaverine, putrescine, spermidine and spermine, wherein no compound has a molecular weight or size of a molecular ion that exceeds 203 Da.
Patent NZ-565327-A (NZ)
Title: A voltage regulation device
Inventor: REDFORD SIMON JAMES
IPC: G05F1/14
Filed: 2005-08-10
Abstract: A voltage regulation device (20) comprises an autotransformer (22) adapted for connection to an electrical supply, cyclic switching means (25) connected to the autotransformer to determine its output voltage, and temperature responsive means (24) responsive to a variation in the operating temperature of the autotransformer and connected to the cyclic switching means to vary the output voltage and thus control the operating temperature. The temperature responsive means is adapted continuously to estimate or measure the working temperature of the autotransformer and in the event of an increase in the temperature to cause the switching logic to increase the set point of the autotransformer.
Patent NZ-566341-A (NZ)
Title: Method and apparatus for monitoring bariatric parameters and sleep disordered breathing
Inventor: HEBBLEWHITE MALCOLM RONALD
IPC: A61M16/00
Filed: 2004-06-18
Abstract: An apparatus for monitoring insulin resistance management with obstructive sleep apnea of a single patient comprises a processor configured for storing data and a display. The data is associated with a time period of interest and relating to an insulin resistance parameter; one or more obstructive sleep apnea parameters and a bariatric parameter. The display is for displaying the insulin resistance data and bariatric data together with one or more obstructive sleep apnea data for the patient in graphical form for a time series to facilitate a comparative monitoring of the insulin resistance, obstructive sleep apnea and bariatric management of the patient. (62) Divided Out of 544109
Patent NZ-567269-A (NZ)
Title: Cycloalkene derivatives for supressing the effects of endotoxins
Inventor: KIMURA TOMIO
IPC: C07D493/10
Filed: 2006-09-13
Abstract: Disclosed is a compound of formula (I), or a pharmacologically acceptable salt thereof, wherein X and Y are either substituents as defined in the specification or together form a ring, l and m are each 0-3 and their sum is 1-3, and wherein the other substituents are as described in the specification. Also disclosed is the use of the compound for suppressing intracellular signal transduction or cell activation induced by endotoxin, and for treating diseases associated with this transduction or activation, such as sepsis.
Patent NZ-568731-A (NZ)
Title: Espresso machine
Inventor: CORKIN ROY
Filed: 2008-06-03
Abstract: An espresso machine is disclosed. The espresso machine includes a water heater for heating a water supply, a valve arrangement in fluid communication with the water heater, a brew head in fluid communication with the valve arrangement via a brew water conduit, a hot water/steam outlet in fluid communication with the valve arrangement via a hot water/steam conduit, a pump for pumping water from the water supply to at least one of the brew head and the hot water/steam outlet via the valve arrangement, and a controller for controlling operation of the valve arrangement to selectively direct fluid flow from the water supply to the brew water conduit or the hot water/steam conduit. The espresso machine also includes a pressure release valve for releasing pressure in the hot water/steam conduit independently of the controller via an overflow outlet.
Patent NZ-571582-A (NZ)
Title: A method for the preparation of k-carrageenase
Inventor: KHAMBHATY YASMIN NAJMUDDIN
IPC: C12N9/42
Filed: 2006-08-29
Abstract: Disclosed is a method for the preparation of k-carrageenase, wherein the said method comprises the steps of: (i) growing the halotolerant marine bacterium, Pseudomonas sp. with accession number MTCC 5261 in a liquid medium to obtain culture; (ii) centrifuging the culture obtained from step (i) to obtain cell free extract as supernatant; iii) purifying the crude enzyme from supernatant obtained from step (ii) to get the pellet containing K-carrageenase; (iv) suspending the pellets obtained from step (iii); and (v) dialyzing the suspension obtained in step (iv) for removing the adhered ammonium sulphate followed by gel filtration to get desired purified K-carrageenase.
Patent NZ-575461-A (NZ)
Title: Method of treating peripheral nerve disorders with an protein which binds C5
Inventor: HAMER JOHN
IPC: A61P25/02
Filed: 2007-09-10
Abstract: Disclosed is the use of an agent that binds complement C5 in the manufacture of a medicament for treating or preventing a peripheral nerve disorder in a subject, wherein the agent that binds C5 is a protein comprising amino acids 19 to 168 of the amino acid sequence in Figure 2 or is a functional homologue or fragment of this protein. Further disclosed is a method of treating or preventing a peripheral nerve disorder in a non-human animal comprising administering to the non-human animal in need thereof an agent that binds complement C5, wherein the agent that binds C5 is a protein comprising amino acids 19 to 168 of the amino acid sequence in Figure 2 or is a functional homologue or fragment of this protein.
Patent NZ-579766-A (NZ)
Title: Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
Inventor: SCHULTZ THOMAS
IPC: C07D403/04
Filed: 2008-03-20
Abstract: Disclosed herein are azetidin derivatives of formula (I), wherein the substituents are as defined within the specification, processes for its preparation, compositions comprising said compounds and uses thereof. Said compounds are useful for treating disorders relating to the modulation of the serotonin 5-HT6 receptor and are therefore useful in treating disorders such as diseases of the central nervous system, addiction diseases, obesity, cognitive dysfunctions associated with Alzheimer's disease and schizophrenia.
Patent NZ-581901-A (NZ)
Title: A sideform system
Inventor: SLADOJEVIC ROBERT
IPC: E04G11/36
Filed: 2007-10-31
Abstract: Disclosed is a sideform for a sideform system, the sideform including an elongate body member defining a side forming face and an opposed mounting portion for mounting the body member on a sideform holder; at least one recessed region, in which an insert is receivable, defined in at least the side forming face of the body member; an engaging arrangement associated with the recessed region for securing the insert in position in the recessed region; and at least one attaching formation arranged on the body member in association with the side forming face for attaching an edge form. An insert can be removably received in the recessed region to define, together with the side forming face of the body member, a predetermined profile to be imparted to a side of a concrete structural element in the precasting of concrete panels.
Patent NZ-582843-A (NZ)
Title: Methods for producing fermentation products
Inventor: DEINHAMMER RANDY
IPC: C12P1/00
Filed: 2008-06-27
Abstract: Disclosed are methods for producing a fermentation product from a lignocellulose-containing material comprising i) pre-treating lignocellulose-containing material; ii) hydrolysing pre-treated lignocellulose-containing material; iii) fermenting using a fermenting organism; wherein fermentation is initiated and carried out at: a) a fermentation organism cell count in the range from 10-250x1010 cells per L fermentation medium; or b) a fermentation organism concentration in the range from 2-90 g dry weight fermenting organism per L fermentation medium.
Patent NZ-586285-A (NZ)
Title: Use of aliskiren in monotherapy for treating diabetes and metabolic disorder (syndrome X)
Inventor: FELDMAN DAVID LOUIS
IPC: A61P9/10
Filed: 2005-03-16
Abstract: Disclosed is the use of 2(S),4(S),5(S),7(S)-N-(3-amino-2,2-d imethyl-3-oxopropyl)-2,7-di(1-methylethyl )-4-hydroxy-5-am ino-8-[4-me thoxy-3-(3-methoxypropoxy)phenyl)-octanamide, also known as aliskiren, in monotherapy for preventing, delaying progression or treating type 2 diabetes and metabolic disorder (syndrome X).
Patent NZ-586950-A (NZ)
Title: Intraocular lens delivery system cartridge with a tubular nozzle
Inventor: DOWNER DAVID A
IPC: A61F2/16
Filed: 2009-02-06
Abstract: 586950 Disclosed is a cartridge for an IOL delivery system (10) that has an injector tip (12) with injector tip geometry designed to reduce stresses at the incision wound edges generated during insertion of an IOL into an eye. The injector tip geometry includes a tubular nozzle having a modified elliptical cross section. The injector tip geometry reduces stresses generated reduce the likelihood of tearing or overstretching the wound during cartridge tip insertion and residence time in the wound while the lens is being delivered into the eye.
Patent NZ-588214-A (NZ)
Title: Methods and apparatus for converting waste materials into fuels and other useful products
Inventor: ADAMS TERRY N
IPC: B01J19/00
Filed: 2009-02-26
Abstract: Disclosed is a process for producing a liquid hydrocarbon fuel from organic waste materials, comprising: preparing a slurry from the waste materials to form a process stream; accumulating a volume of the process stream in a stirred vessel after said preparing at a temperature of between about 60-70 ºC; heating the process stream to a temperature between about 125-200 ºC at a pressure between about 20-600 psig to decompose solid organic materials and separate organic from inorganic materials; separating solids resulting from said decomposing from the process stream; accumulating a volume of the process stream in an agitated vessel after said separating at a temperature of between about 115-180 ºC and a pressure of between about 15-175 psig; monitoring at least one parameter of the process stream; heating the process stream to a temperature of between about 200-270 ºC at a pressure between about 210-800 psig to hydrolyse the process stream; flashing the process stream to a lower pressure after said hydrolysis to remove steam and non-condensable gases; removing entrained solids from the process stream after flashing; and separating water from the process stream to produce a liquid hydrocarbon fuel. Further disclosed is a system / apparatus for performing said method, and a liquid hydrocarbon fuel produced by the above process is also described.
Patent NZ-588460-A (NZ)
Title: Oral pharmaceutical compositions in a solid dispersion comprising preferably posaconazole and hpmcas
Inventor: FANG LARRY YUN
IPC: A61K31/00
Filed: 2009-04-15
Abstract: A composition comprising posaconazole dissolved or molecularly dispersed in a hydroxypropylmethyl-cellulose-derivative polymer is disclosed, wherein, when an amount of the composition comprising at least about 100 mg of posaconazole is administered orally to a human under fasted conditions, at least one of the following PK median parameters are observed: Cmax in at least about 300 ng/mL; or an AUC(tf) of at least about 10,000 hr.ng/mL.Also disclosed is a process for preparing a composition comprising posaconazole and hydroxypropylmethylcellulose acetate succinate, the process comprises the steps of: (a) dry-blending HPMC-AS and posaconazole in a ratio of from about 1:1 (HPMC-AS:posaconazole) to about 4:1 (HPMC-AS:posaconazole) to form a homogeneous admixture; (b) heating the admixture prepared in step "a" to a temperature below the glass transition temperature of the HPMC-AS present in the mixture and above the fluxing temperature of the mixture, thereby forming a melt, optionally while blending the admixture; and (c) cooling the melt formed in Step "b", thereby providing a solid composition comprising posaconazole dissolved or molecularly dispersed in HPMC-AS.
Patent NZ-588748-A (NZ)
Title: Super fast-acting insulin compositions comprising insulin analogs and a hyaluronan degrading enzyme
Inventor: FROST GREGORY I
IPC: A61K38/28
Filed: 2009-04-28
Abstract: Disclosed is a super fast-acting insulin composition, comprising: a therapeutically effective concentration of a fast-acting insulin analog for maintaining normal blood glucose levels, wherein the blood glucose levels are prandial blood glucose levels; and a concentration of a hyaluronan degrading enzyme sufficient to render the composition a super fast-acting insulin composition upon administration, wherein the super fast-acting insulin composition has an onset of action that is faster than the analog alone, and a duration of action that is shorter than the analog alone, whereby, upon administration, the composition closely mimics the physiologic post-prandial insulin release of a non-diabetic subject to achieve glycemic control; and the super fast-acting insulin composition is formulated for a route of administration selected from among subcutaneous, intradermal, intramuscular and intraperitoneal administration.
Patent NZ-588889-A (NZ)
Title: Testing for moisture in a building using two wires with sensors able to connect to the wires at different sites using switches
Inventor: HOLYOAKE IAN CONRAD
IPC: G01N27/04
Filed: 2009-07-01
Abstract: Disclosed are means for detecting water or moisture in a building, or a quality of a building material within the building. The means include an electrical first line (401) extending to measurement sites at timber framing within the building; an electrical second line (402) extending to the same measurement sites; moisture sensors (403) connected to the lines at different sites, each sensor having a respective switch means (405); a resistance meter (404) which can be connected to the lines; and means for opening and closing the switch means. When a switch means is closed a circuit is formed so that respective sensor is active to enable readings for that sensor to be taken at the meter (62) Divided Out of 578082
Patent NZ-590074-A (NZ)
Title: Prostaglandin e2 dual variable domain immunoglobulins and uses thereof
Inventor: GHAYUR TARIQ
IPC: C12P21/08
Filed: 2009-07-08
Abstract: Disclosed is a binding protein comprising a polypeptide chain, wherein said polypeptide chain comprises VDl-(Xl)n-VD2-C-(X2)n, wherein; VDl is a first heavy chain variable domain; VD2 is a second heavy chain variable domain; C is a heavy chain constant domain; Xl is a linker with the proviso that it is not CHl; X2 is an Fc region; and n is 0 or 1; wherein the binding protein is capable of binding a pair of antigens selected from the group consisting of TNF and PGE2, NGF and PGE2, IL- 17A and PGE2, IL-Ib and PGE2, IL-6 and PGE2, IL-6R and PGE2, VEGF and PGE2, Abeta (seq. 1) and PGE2, Abeta (seq. 2) and PGE2, Abeta (seq. 3) and PGE2, IL- 18 and PGE2, PGE2 and PGE2, IL-15 and PGE2, SlP and PGE2, EGFR (seq. 1) and PGE2, EGFR (seq. 2) and PGE2, and IGFR and PGE2.
Patent NZ-597005-A (NZ)
Title: Method for detoxification of lipopolysaccharide (lps) or of lipid a of gram-negative bacteria
Inventor: HAENSLER JEAN
IPC: A61K39/00
Filed: 2010-05-12
Abstract: Provided is a method for detoxification of lipopolysaccharide (LPS) or of lipid A from a Gram-negative bacterium, according to which the LPS or the lipid A is mixed with a cationic lipid so as to form a complex in which the LPS or the lipid A is associated with the cationic lipid. The LPS may be from Neisseria meningitidis.
Patent NZ-598485-A (NZ)
Title: Benzimidazole trpv1 inhibitors
Inventor: CHEUNG WING S
IPC: A01N43/50
Filed: 2007-12-12
Abstract: ABSTRACT - 598485 The disclosure relates to benzoxazolyl, benzothiazolyl and benzoimidazolyl substituted polymeric styryl compounds represented by formula (I), wherein the variables are as defined in the specification. These compounds are suitable for treating a TRPV1 ion channel mediated disease selected from chronic or acute pain due to a disease that causes inflammatory pain, burning pain or post-operative pain in a subject.
Patent NZ-601656-A (NZ)
Title: Pyridyloxyindoles inhibitors of VEGF-R2 and use thereof for treatment of disease
Inventor: RAO CHANG
IPC: A61K31/404
Filed: 2009-12-07
Abstract: 601656 Disclosed is a carboxamide and fused pyrimidine substituted indole of formula (III) where the substituents R8 and R9 form a heterocyclic ring and the other substituents are as disclosed in the specification. Examples of a compound of formula (III) are: (±)-4-[1-(5-Cyclopropyl-isoxazol-3-ylcarbamoyl)-1H-indol-5-yloxy]-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine-6-carboxylic acid methylamide; 5-(6,7-Dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-yloxy)-indole-1-carboxylic acid (5-{ 1-[(2-methoxy-ethylamino)-methyl]-cyclopropyl} -isoxazol-3-yl)-amide and 5-(6,7-Dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-yloxy)-indole-1-carboxylic acid [5-(1-methylaminomethyl-cyclopropyl)-isoxazol-3-yl]-amide. Also disclosed are pharmaceutical combinations comprising a compound of formula (III) the use of a compound of formula (III) in the manufacture of a medicament and a method of treating a VEGF-R mediated disease in a non-human animal by administering a compound of formula (III).